European Union edges closer to fast-tracking gene edited crop approvals, debating plan to shelve activst and organic industry-supported patent restrictions

AQOR22XsUO-ZrxTMOmKkUOE5_8PO233R7HIEdsHXnrPi5OItQArQfRLsCA_ATeUlXdZMn_HDr0JrQ8vMVGY8N14Mh4vQISTzYik89Tc-02Yl4y9vQIVDUjP7ucgUKGhn
The Polish Presidency have proposed an amendment which removes the proposed patent ban for NGT [gene edited] plants, plant material and plant products.

In preparing legislation to relax the regulatory process for the marketing of NGT plants, the EU Parliament proposed an amendment which effectively excluded from patentability “NGT plants, parts thereof, genetic information, and the process features they contain”.  The proposal also included restrictions on the scope of protection of existing patents and applications for all NGT plants.  The purpose of the proposed ban was to avoid legal uncertainties, increased costs and dependencies on large agritech companies for farmers and breeders.  This, they argued, was in line with the EU Commission aim to develop sustainable agriculture and increase food security in the region.

Since the proposed amendment, there has been debate over the scope of the exclusion, which could have been interpreted as extending to the genetic tools used for targeted mutagenesis.  There has also been understandable reluctance in having to revise existing legislation such as the EU Biotech Directive, the UPCA and the Trips agreement, as well as questions over the amendments that might be needed to the European Patent Convention.  Despite softening the proposal to be limited to the lower-risk NGT1 plants only by the Belgian Presidency, they were unable to secure a majority vote.

The current Polish presidency have recognised that in order to implement the regulatory legislation, the deadlock between the EU member states on the proposed patent ban has to be promptly addressed.  With the objective of stimulating innovation in the EU whilst enabling free access to varieties by breeders, the Polish Presidency have proposed the following:

  • There will be a distinction between patents which protect basic technologies and patents for plants and processes which result in a specific plant trait.
  • Reproductive material of an NGT1 plant can be placed on the market without any further restrictions, if it is not protected by a product patent, or a process patent which results in a specific trait of the plant.
  • If there are patents which protect the reproductive material, or which protect a process which results in a specific trait, then the reproductive material can still be put on the market, but it may be subject to further restrictions if a Member State wishes. Such restrictions include: a ban on use of the reproductive material for cultivation of reproductive material and a labelling requirement.  These restrictions would aim to protect national farmers and breeders against patents.
  • The proposal includes a verification procedure to determine the existence of patents or applications which may be relevant, and this burden will fall to the party putting the reproductive material on the market.

It is notable that the provisions don’t relate to plants per se, or plant products but only to reproductive material.  The requirements are also limited to NGT1 plants, and any other reproductive material will not be subject to the verification procedure.

Many have welcomed the removal of the proposed patent ban, and if the Polish proposal is accepted then the legislation may progress forward, although there are still many non-IP related issues to resolve.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jul-22-2026-09_13_07-AM
Viewpoint—The Strategic Litigation boom: Understanding the tightening coalition among NGOs, foundations, journalists, and tort lawyers
close up arabica coffee farmer s hands picking beans plant his farm colombia
Viewpoint: Why do so many ‘mainstream’ and ‘respected’ media outlets exaggerate climate change threats?
How to Include More Strawberries in Your Diet
Strawberries are berries—and 35 other surprising food and drink myths
diversity
We are entering a new era of personalized medicine—if you’re white
Screenshot-2026-07-07-at-12.55.44-PM
Viewpoint: Yes, we can adapt to a changing climate without devastating the environment and the economy
ChatGPT-Image-May-22-2026-10_26_09-AM
Trump-RFK, Jr. National Science Board firings: Accountability vs. partisan meddling
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
organic scaled
Facts & Fallacies podcast: Organic food cuts pesticide exposure? A response to Dr. Rhonda Patrick
Screenshot 2026-07-22 at 10.25
Science brain drain escalates as Trump purge extends to USDA
ChatGPT-Image-Jul-6-2026-02_25_26-PM
40 million Americans take glucosamine. If you have memory loss, it could accelerate cognitive decline.
using genetics to reverse aging
Is the longevity obsession a new form of ageism?
Screenshot-2026-07-01-at-2.49.48-PM
Dr. TikTok and male fertility: Viral claims tout GLP-1 drugs as fertility boosters. What does the science say?
kratom
Viewpoint: Kratom ‘supplement’ crisis: DEA sits on its hands while patient addictions to this ineffective drug  rise
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.